Literature DB >> 17022746

Coagulation cascade.

David Green1.   

Abstract

The coagulation cascade is now recognized to be a series of proteolytic events mainly localized to the surface of activated platelets. Once platelets become activated by exposure to activated endothelium, they release mediators such as P-selectin and von Willebrand factor that promote microvesicle formation and platelet adherence. The microvesicles fuse with the activated platelet membrane, providing tissue factor and its ligand, factor VIIa. Clotting factors bind to adjacent receptors on the membrane, enabling the cascading proteolytic cleavages of zymogens to active enzymes, culminating in thrombin generation. Fibrin formation thus occurs in the sheltered environment of the platelet membrane, where it is localized to the site of injury and protected from circulating inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17022746     DOI: 10.1111/j.1542-4758.2006.00119.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  20 in total

1.  The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study.

Authors:  Roberto Romero; Offer Erez; Eli Maymon; Piya Chaemsaithong; Zhonghui Xu; Percy Pacora; Tinnakorn Chaiworapongsa; Bogdan Done; Sonia S Hassan; Adi L Tarca
Journal:  Am J Obstet Gynecol       Date:  2017-03-03       Impact factor: 8.661

2.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

3.  Extensive deendothelialization and thrombogenicity in routinely prepared vein grafts for coronary bypass operations: facts and remedy.

Authors:  Dominik R Weiss; Gerd Juchem; Bernhard M Kemkes; Brigitte Gansera; Stephan Nees
Journal:  Int J Clin Exp Med       Date:  2009-05-28

4.  Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Richard M Silver
Journal:  Arthritis Rheum       Date:  2009-11

5.  A natural prodrug activation mechanism in nonribosomal peptide synthesis.

Authors:  Daniela Reimer; Klaas M Pos; Marco Thines; Peter Grün; Helge B Bode
Journal:  Nat Chem Biol       Date:  2011-09-18       Impact factor: 15.040

6.  Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.

Authors:  Galina S Bogatkevich; Anna Ludwicka-Bradley; Paul J Nietert; Tanjina Akter; Joanne van Ryn; Richard M Silver
Journal:  Arthritis Rheum       Date:  2011-05

Review 7.  Topically applied heparins for the treatment of vascular disorders : a comprehensive review.

Authors:  Cesare Vecchio; Anna Frisinghelli
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

8.  Optical Thromboelastography to evaluate whole blood coagulation.

Authors:  Zeinab Hajjarian; Markandey M Tripathi; Seemantini K Nadkarni
Journal:  J Biophotonics       Date:  2014-04-03       Impact factor: 3.207

9.  Effect of mild hypothermia on the coagulation-fibrinolysis system and physiological anticoagulants after cardiopulmonary resuscitation in a porcine model.

Authors:  Ping Gong; Ming-Yue Zhang; Hong Zhao; Zi-Ren Tang; Rong Hua; Xue Mei; Juan Cui; Chun-Sheng Li
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

10.  Thrombin-induced CCN2 expression as a target for anti-fibrotic therapy in scleroderma.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2009-12-03       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.